Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Rhythm Pharmaceuticals (RYTM) Interest Coverage Ratio: 2022-2025

Historic Interest Coverage Ratio for Rhythm Pharmaceuticals (RYTM) over the last 3 years, with Sep 2025 value amounting to -11.10.

  • Rhythm Pharmaceuticals' Interest Coverage Ratio fell 32.63% to -11.10 in Q3 2025 from the same period last year, while for Sep 2025 it was -8.70, marking a year-over-year increase of 37.29%. This contributed to the annual value of -12.89 for FY2024, which is 2.89% up from last year.
  • Rhythm Pharmaceuticals' Interest Coverage Ratio amounted to -11.10 in Q3 2025, which was down 42.59% from -7.79 recorded in Q2 2025.
  • In the past 5 years, Rhythm Pharmaceuticals' Interest Coverage Ratio ranged from a high of -7.57 in Q4 2024 and a low of -29.42 during Q1 2024.
  • For the 3-year period, Rhythm Pharmaceuticals' Interest Coverage Ratio averaged around -12.37, with its median value being -9.07 (2023).
  • As far as peak fluctuations go, Rhythm Pharmaceuticals' Interest Coverage Ratio crashed by 71.43% in 2024, and later soared by 70.46% in 2025.
  • Rhythm Pharmaceuticals' Interest Coverage Ratio (Quarterly) stood at -13.98 in 2022, then spiked by 35.14% to -9.07 in 2023, then grew by 16.49% to -7.57 in 2024, then tumbled by 32.63% to -11.10 in 2025.
  • Its Interest Coverage Ratio stands at -11.10 for Q3 2025, versus -7.79 for Q2 2025 and -8.69 for Q1 2025.